SURF
Surface Oncology, Inc. Common Stock
SURF
SURF
Delisted
SURF was delisted on the 7th of September, 2023.
79 hedge funds and large institutions have $74.2M invested in Surface Oncology, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
47% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 30
Holders
79
Holding in Top 10
1
Calls
$108K
Puts
$10K
Top Buyers
| 1 | +$4.07M | |
| 2 | +$352K | |
| 3 | +$157K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$128K |
| 5 |
Jane Street
New York
|
+$108K |
Top Sellers
| 1 | -$640K | |
| 2 | -$384K | |
| 3 | -$286K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$260K |
| 5 |
Barclays
London,
United Kingdom
|
-$255K |